Local anesthetic transperineal (LATP) biopsy for prostate cancer detection is gaining in popularity due to concerns about infectious complications with transrectal ultrasound (TRUS) biopsy.

Transperineal prostate biopsy improves cancer detection, especially in repeat biopsies, with fewer complications.

The results show that transperineal biopsy is better at diagnosing clinically meaningful prostate cancer, and that the men having this type of biopsy did not need antibiotics, which is important to ...

Richard Szabo, MD, a prostate biopsy researcher at University of California Irvine, said the reduction in post-biopsy sepsis has been “an additional major advantage” of transperineal over ...

A new study provides the strongest evidence to date on the clinical utility of a polygenic score for prostate cancer ...

"The results show that transperineal biopsy is better at diagnosing clinically meaningful prostate cancer, and that the men having this type of biopsy did not need antibiotics, which is important ...

Nearly all men with a polygenic risk score in the 90th percentile or above had a 10-year absolute risk for prostate cancer exceeding 3.8%. A polygenic risk score (PRS) identifies more patients with ...

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...

As per Vantage Market Research, the Global Fusion Biopsy Market has been rapidly growing due to the advancements in medical imaging technology, the increasing prevalence of prostate cancer, and the ...

Biopsy with local anesthetic ultrasound-guided transperineal (LATP) identified more clinically significant prostate cancers than transrectal ultrasound (TRUS), but the procedure came with ...